<p>Health Catalyst, Inc.（納斯達克代碼：HCAT - 獲取免費報告）董事 Julie Larson-Green 於 12 月 4 日星期四出售了 47,997 股公司的股票。該股票以平均價格 2.67 美元出售，總價值為 128,151.99 美元。交易完成後，該董事在公司持有 73,573 股，價值 196,439.91 美元。這代表其持股比例減少了 39.48%。該交易已在與證券交易委員會的法律文件中披露，您可以通過此鏈接訪問。</p>
<p>獲取 <strong>Health Catalyst</strong> 的提醒：</p>
<h2>Health Catalyst 股價下跌 1.1%</h2>
<ul>
<li>健康科技復甦：3 只股票有望在 2025 年大幅反彈</li>
</ul>
<p>在週二的交易中，納斯達克 HCAT 股價下跌 0.03 美元，達到 2.61 美元。493,261 股股票易手，交易量低於其平均交易量 704,965 股。Health Catalyst, Inc.的 52 周最低價為 2.02 美元，52 周最高價為 8.52 美元。該公司的速動比率為 1.88，流動比率為 1.88，債務與股本比率為 0.46。該公司的市值為 1.8461 億美元，市盈率為-1.64，貝塔值為 1.72。該股票的 50 日移動平均價格為 2.83 美元，200 日移動平均價格為 3.30 美元。</p>
<p>Health Catalyst（納斯達克代碼：HCAT - 獲取免費報告）最近在 11 月 10 日星期一發布了季度財報。該公司報告本季度每股收益為 0.06 美元，超出市場共識預期的 0.05 美元，超出 0.01 美元。Health Catalyst 的股本回報率為-6.67%，淨利潤率為-34.05%。該公司本季度的收入為 7632 萬美元，超過市場共識預期的 7505 萬美元。分析師預測 Health Catalyst, Inc.本年度將發佈-0.33 美元的每股收益。</p>
<h2>華爾街分析師觀點</h2>
<ul>
<li>2021 年 6 月華爾街分析師推薦的 10 只頂級股票</li>
</ul>
<p>HCAT 已成為多份研究報告的主題。Piper Sandler 在 8 月 27 日星期三的研究報告中將 Health Catalyst 的評級從 “超配” 下調至 “中性”，並將其目標價從 8.00 美元下調至 4.00 美元。瑞銀集團在 11 月 11 日星期二的報告中重申了對 Health Catalyst 股票的 “跑贏大盤” 評級。花旗集團在 11 月 11 日星期二的研究報告中將 Health Catalyst 股票的目標價從 3.50 美元下調至 3.25 美元，並對該公司設定了 “中性” 評級。Evercore ISI 在 10 月 8 日星期三的報告中將 Health Catalyst 股票的目標價從 4.00 美元下調至 3.00 美元，並對該股票設定了 “持平” 評級。最後，加拿大皇家銀行在 8 月 29 日星期五的研究報告中將 Health Catalyst 股票的目標價從 9.00 美元下調至 5.00 美元，並對該公司設定了 “買入” 評級。五家股票研究分析師對該股票給予了買入評級，八家給予了持有評級，一家給予了賣出評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價為 4.36 美元。</p>
<p><strong>獲取我們對 Health Catalyst 的最新分析</strong></p>
<h2>機構資金流入和流出</h2>
<p>最近，一些對沖基金買入和賣出了 HCAT 的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Health Catalyst 的股份增加了 7.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前擁有 36,047 股公司股票，價值 163,000 美元，此前在上個季度購買了 2,624 股。Campbell &amp; CO Investment Adviser LLC 在第二季度將其在 Health Catalyst 的股份增加了 9.7%。Campbell &amp; CO Investment Adviser LLC 目前擁有 43,051 股公司股票，價值 162,000 美元，此前在上個季度購買了 3,808 股。製造商人壽保險公司在第二季度將其在 Health Catalyst 的持股增加了 19.6%。製造商人壽保險公司目前擁有 26,491 股公司股票，價值 100,000 美元，此前在上個季度購買了 4,341 股。法國巴黎銀行金融市場在第三季度將其在 Health Catalyst 的持股增加了 71.7%。法國巴黎銀行金融市場目前擁有 16,355 股公司股票，價值 47,000 美元，此前在上個季度購買了 6,832 股。最後，Probity Advisors Inc.在第三季度將其在 Health Catalyst 的持股增加了 20.5%。Probity Advisors Inc.目前擁有 45,161 股公司股票，價值 129,000 美元，此前在上個季度購買了 7,671 股。85.00% 的股票目前由機構投資者持有。</p>
<h2>關於 Health Catalyst</h2>
<p>（獲取免費報告）</p>
<p>Health Catalyst, Inc.為美國的醫療組織提供數據和分析技術及服務。它分為兩個部門，技術和專業服務。該公司提供數據操作系統數據平台，為客户提供一個綜合環境，以整合和組織來自不同軟件系統的數據；以及分析應用程序，這是為數據平台構建的軟件分析應用程序，用於分析客户在臨牀和質量、人口健康以及財務和運營用例方面面臨的問題。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票比 Health Catalyst 更好</li>
<li>什麼是股票市場指數，如何使用它們？</li>
<li>消費者得到了煤炭，但聖誕老人給這兩家零售商帶來了巨大的收益</li>
<li>銀行股票 - 最佳銀行股票投資指南</li>
<li>10 倍收益？這三隻機器人股票可能在 2035 年爆發</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>安海斯 - 布希收購 BeatBox 以吸引年輕飲酒者</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在 Health Catalyst 嗎？</h2>
<p>在考慮 Health Catalyst 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦在更廣泛的市場注意到之前購買……而 Health Catalyst 並不在名單上。</p>
<p>雖然 Health Catalyst 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HCAT

<p>Health Catalyst 董事 Julie Larson-Green 出售了 47,997 股，交易金額為 128,151.99 美元，減持幅度為 39.48%。此次出售在 SEC 文件中披露。Health Catalyst 的股票下跌 1.1%，報 2.61 美元，市值為 1.8461 億美元。分析師的評級不一，平均目標價為 4.36 美元。機構投資者已調整在該公司的持股</p>

<p>Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) Director Julie Larson-Green sold 47,997 shares of the firm's stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $2.67, for a total value of $128,151.99. Following the completion of the transaction, the director owned 73,573 shares in the company, valued at $196,439.91. This represents a 39.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink.</p>
<div class="lb-trans"><p>Health Catalyst, Inc.（納斯達克代碼：HCAT - 獲取免費報告）董事 Julie Larson-Green 於 12 月 4 日星期四出售了 47,997 股公司的股票。該股票以平均價格 2.67 美元出售，總價值為 128,151.99 美元。交易完成後，該董事在公司持有 73,573 股，價值 196,439.91 美元。這代表其持股比例減少了 39.48%。該交易已在與證券交易委員會的法律文件中披露，您可以通過此鏈接訪問。</p>
</div><p>Get <strong>Health Catalyst</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Health Catalyst</strong> 的提醒：</p>
</div><h2>Health Catalyst Trading Down 1.1%</h2>
<div class="lb-trans"><h2>Health Catalyst 股價下跌 1.1%</h2>
</div><ul>
<li>Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound</li>
</ul>
<div class="lb-trans"><ul>
<li>健康科技復甦：3 只股票有望在 2025 年大幅反彈</li>
</ul>
</div><p>NASDAQ HCAT traded down $0.03 during trading on Tuesday, reaching $2.61. 493,261 shares of the stock traded hands, compared to its average volume of 704,965. Health Catalyst, Inc. has a fifty-two week low of $2.02 and a fifty-two week high of $8.52. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.46. The firm has a market cap of $184.61 million, a price-to-earnings ratio of -1.64 and a beta of 1.72. The stock's 50-day moving average price is $2.83 and its 200 day moving average price is $3.30.</p>
<div class="lb-trans"><p>在週二的交易中，納斯達克 HCAT 股價下跌 0.03 美元，達到 2.61 美元。493,261 股股票易手，交易量低於其平均交易量 704,965 股。Health Catalyst, Inc.的 52 周最低價為 2.02 美元，52 周最高價為 8.52 美元。該公司的速動比率為 1.88，流動比率為 1.88，債務與股本比率為 0.46。該公司的市值為 1.8461 億美元，市盈率為-1.64，貝塔值為 1.72。該股票的 50 日移動平均價格為 2.83 美元，200 日移動平均價格為 3.30 美元。</p>
</div><p>Health Catalyst (NASDAQ:HCAT - Get Free Report) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.05 by $0.01. Health Catalyst had a negative return on equity of 6.67% and a negative net margin of 34.05%.The business had revenue of $76.32 million for the quarter, compared to the consensus estimate of $75.05 million. Analysts predict that Health Catalyst, Inc. will post -0.33 EPS for the current year.</p>
<div class="lb-trans"><p>Health Catalyst（納斯達克代碼：HCAT - 獲取免費報告）最近在 11 月 10 日星期一發布了季度財報。該公司報告本季度每股收益為 0.06 美元，超出市場共識預期的 0.05 美元，超出 0.01 美元。Health Catalyst 的股本回報率為-6.67%，淨利潤率為-34.05%。該公司本季度的收入為 7632 萬美元，超過市場共識預期的 7505 萬美元。分析師預測 Health Catalyst, Inc.本年度將發佈-0.33 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><ul>
<li>The 10 Top-Rated Stocks by Wall Street Analysts in June 2021</li>
</ul>
<div class="lb-trans"><ul>
<li>2021 年 6 月華爾街分析師推薦的 10 只頂級股票</li>
</ul>
</div><p>HCAT has been the subject of a number of research reports. Piper Sandler cut Health Catalyst from an &#34;overweight&#34; rating to a &#34;neutral&#34; rating and lowered their target price for the stock from $8.00 to $4.00 in a research note on Wednesday, August 27th. UBS Group reiterated an &#34;outperform&#34; rating on shares of Health Catalyst in a report on Tuesday, November 11th. Citigroup lowered their price objective on shares of Health Catalyst from $3.50 to $3.25 and set a &#34;neutral&#34; rating for the company in a research report on Tuesday, November 11th. Evercore ISI dropped their price objective on shares of Health Catalyst from $4.00 to $3.00 and set an &#34;in-line&#34; rating on the stock in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group reduced their target price on shares of Health Catalyst from $9.00 to $5.00 and set a &#34;buy&#34; rating for the company in a research note on Friday, August 29th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Hold&#34; and an average target price of $4.36.</p>
<div class="lb-trans"><p>HCAT 已成為多份研究報告的主題。Piper Sandler 在 8 月 27 日星期三的研究報告中將 Health Catalyst 的評級從 “超配” 下調至 “中性”，並將其目標價從 8.00 美元下調至 4.00 美元。瑞銀集團在 11 月 11 日星期二的報告中重申了對 Health Catalyst 股票的 “跑贏大盤” 評級。花旗集團在 11 月 11 日星期二的研究報告中將 Health Catalyst 股票的目標價從 3.50 美元下調至 3.25 美元，並對該公司設定了 “中性” 評級。Evercore ISI 在 10 月 8 日星期三的報告中將 Health Catalyst 股票的目標價從 4.00 美元下調至 3.00 美元，並對該股票設定了 “持平” 評級。最後，加拿大皇家銀行在 8 月 29 日星期五的研究報告中將 Health Catalyst 股票的目標價從 9.00 美元下調至 5.00 美元，並對該公司設定了 “買入” 評級。五家股票研究分析師對該股票給予了買入評級，八家給予了持有評級，一家給予了賣出評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價為 4.36 美元。</p>
</div><p><strong>Get Our Latest Analysis on Health Catalyst</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 Health Catalyst 的最新分析</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of hedge funds have recently bought and sold shares of HCAT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Health Catalyst by 7.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company's stock worth $163,000 after purchasing an additional 2,624 shares in the last quarter. Campbell &amp; CO Investment Adviser LLC grew its stake in shares of Health Catalyst by 9.7% in the second quarter. Campbell &amp; CO Investment Adviser LLC now owns 43,051 shares of the company's stock valued at $162,000 after buying an additional 3,808 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in Health Catalyst by 19.6% during the second quarter. The Manufacturers Life Insurance Company now owns 26,491 shares of the company's stock worth $100,000 after buying an additional 4,341 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in Health Catalyst by 71.7% during the third quarter. BNP Paribas Financial Markets now owns 16,355 shares of the company's stock worth $47,000 after buying an additional 6,832 shares during the last quarter. Finally, Probity Advisors Inc. raised its position in Health Catalyst by 20.5% during the third quarter. Probity Advisors Inc. now owns 45,161 shares of the company's stock worth $129,000 after acquiring an additional 7,671 shares in the last quarter. 85.00% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>最近，一些對沖基金買入和賣出了 HCAT 的股票。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度將其在 Health Catalyst 的股份增加了 7.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前擁有 36,047 股公司股票，價值 163,000 美元，此前在上個季度購買了 2,624 股。Campbell &amp; CO Investment Adviser LLC 在第二季度將其在 Health Catalyst 的股份增加了 9.7%。Campbell &amp; CO Investment Adviser LLC 目前擁有 43,051 股公司股票，價值 162,000 美元，此前在上個季度購買了 3,808 股。製造商人壽保險公司在第二季度將其在 Health Catalyst 的持股增加了 19.6%。製造商人壽保險公司目前擁有 26,491 股公司股票，價值 100,000 美元，此前在上個季度購買了 4,341 股。法國巴黎銀行金融市場在第三季度將其在 Health Catalyst 的持股增加了 71.7%。法國巴黎銀行金融市場目前擁有 16,355 股公司股票，價值 47,000 美元，此前在上個季度購買了 6,832 股。最後，Probity Advisors Inc.在第三季度將其在 Health Catalyst 的持股增加了 20.5%。Probity Advisors Inc.目前擁有 45,161 股公司股票，價值 129,000 美元，此前在上個季度購買了 7,671 股。85.00% 的股票目前由機構投資者持有。</p>
</div><h2>About Health Catalyst</h2>
<div class="lb-trans"><h2>關於 Health Catalyst</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.</p>
<div class="lb-trans"><p>Health Catalyst, Inc.為美國的醫療組織提供數據和分析技術及服務。它分為兩個部門，技術和專業服務。該公司提供數據操作系統數據平台，為客户提供一個綜合環境，以整合和組織來自不同軟件系統的數據；以及分析應用程序，這是為數據平台構建的軟件分析應用程序，用於分析客户在臨牀和質量、人口健康以及財務和運營用例方面面臨的問題。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Health Catalyst</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li>
<li>Bank Stocks - Best Bank Stocks to Invest In</li>
<li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Health Catalyst 更好</li>
<li>什麼是股票市場指數，如何使用它們？</li>
<li>消費者得到了煤炭，但聖誕老人給這兩家零售商帶來了巨大的收益</li>
<li>銀行股票 - 最佳銀行股票投資指南</li>
<li>10 倍收益？這三隻機器人股票可能在 2035 年爆發</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>安海斯 - 布希收購 BeatBox 以吸引年輕飲酒者</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=HCAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Health Catalyst Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Health Catalyst 嗎？</h2>
</div><p>Before you consider Health Catalyst, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Health Catalyst 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health Catalyst wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦在更廣泛的市場注意到之前購買……而 Health Catalyst 並不在名單上。</p>
</div><p>While Health Catalyst currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Health Catalyst 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Health Catalyst (NASDAQ:HCAT) 的一位董事出售了價值 128,151.99 美元的股票